Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This is an open label, randomized, two arm, multi-center study to explore the effect of leronlimab on the overall response rate/ overall survival and safety and tolerability when used in combination with trifluridine and tipiracil + bevacizumab in patients with CCR5+, MSS, mCRC who have progressed on prior treatment before participating in the study. The main questions this study aims to answer are: 1. Can leronlimab, in combination with standard of care therapies trifluridine and tipiracil+ be
Sponsor: CytoDyn, Inc.
Check if you qualify for this colorectal cancer clinical trial in San Francisco, CA
If you're searching for colorectal cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.